528
Participants
Start Date
May 20, 2020
Primary Completion Date
October 31, 2023
Study Completion Date
December 31, 2023
Anlotinib hydrochloride capsule
Anlotinib hydrochloride capsule 12mg given orally in fasting conditions, once daily in 21-day cycle (14 days on treatment from Day 1-14, 7 days off treatment from Day 15-21).
AK105 injection
AK105 200mg intravenously (IV) on Day 1 of each 21-day cycle.
Paclitaxel injection
Paclitaxel injection 80mg / m² IV on Days 1, 8 and 15 of each 28-day cycle.
Docetaxel injection
Docetaxel injection 75mg / m² IV every 3 weeks of each 21-day cycle.
Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing
The Sixth Medical Center of PLA General Hospital, Beijing
Peking University Shougang Hospital, Beijing
Beijing Luhe Hospital Capital Medical University, Beijing
Beijing Tsinghua Changgung Hospital, Beijing
Liaoning Cancar Hospital, Shenyang
Harbin Medical University Cancer Hospital, Harbin
Shanghai General Hospital, Shanghai
Jiangsu Cancer Hospital, Nanjing
Jiangsu Province Hospital, Nanjing
Wuxi People's Hospital, Wuxi
Hospital of Jiangnan University, Wuxi
Nantong Cancer Hospital, Nantong
The First Affiliated Hospital of Anhui Medical University, Hefei
Shandong Cancer Hospital, Jinan
Tianjin Medical University General Hospital, Tianjing
Tianjin Medical University Cancer Institute and Hospital, Tianjing
The First Affiliated Hospital of Nanchang University, Nanchang
Fujian Provincial Cancer Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
Zhongshan Hospital Xiamen University, Xiamen
Quanzhou First Hospital, Quanzhou
The Second Affiliated Hospital of Fujian Medical University, Quanzhou
Xiangya Hospital Central South University, Changsha
The Second Xiangya Hospital of Central South University, Changsha
Hunan Cancer Hospital, Changsha
Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan
Hubei Cancer Hospital, Wuhan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Henan Cancer Hospital, Zhengzhou
Xinxiang Central Hospital, Xinxiang
AnYang Tumor Hospital, Anyang
Sun Yat-Sen University Cancer Center, Guangzhou
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou
Affiliated Hospital of Guangdong Medical University, Zhanjiang
Guangxi Medical University Affiliated Tumor Hospital, Nanning
The Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an
First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
The First Hospital of Lanzhou University, Lanzhou
Gansu Wuwei Tumour Hospital, Wuwei
People's Hospital of Ningxia Hui Autonomous Region, Yinchuan
The First People's Hospital of kashi region, Kashgar
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Shanxi Provincial Cancer Hospital, Taiyuan
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY